Video Shorts

Big FDA & EMA Changes for Rare Disease Therapies

The Challenges Bringing Pharma and Biotech Manufacturing Back to the U.S.

Why Employers Are Blocking Obesity Drugs?

How Novavax’s Protein-Based Vaccine Technology Works

Market Watch Rx: Medtronic Leads Gainers

Tackling Duplicate Discounts

Why Basket Trials Are Changing Rare Disease Research

Market Watch Rx: Cigna Joins Top Gainers

Solving the Healthcare Cost Crisis Through Collective Action

Market Watch Rx: Editas Medicine Leads Gainers

The First Amendment's Impact on DTC Prescription Drug Ads

Improving FDA & Biopharma's Relationship

Big Pharma’s Next Big Shift: Rare Diseases vs. Mass Markets

Market Watch Rx: Baxter International Leads Gainers

FDA's Shift: Why Predictability Now Matters More Than Speed

Using Data to Come to the Right Conclusions

Market Watch Rx: Humana Leads Top Gainers

FDA Leadership Turnover Explained

Solving the ADHD Medication 'Crash' Problem

Market Watch Rx: Eli Lilly Joins Top Gainers

Why the US Healthcare System is Fragmented

Why Patient Care is the Heart of Pharma Business

Market Watch Rx: West Pharmaceutical Services Leads Gainers

Why 'Just-In-Time' Delivery is a Trap

The United State's Regulatory Impact on Global Drug Launches

Market Watch Rx: Johnson & Johnson Shares Slide

Real Hope: The Best Part of Being an Oncologist

How Platform Technologies and Partnerships are Shaping CGT Development

Branding's Hidden Power

Market Watch Rx: Roche Joins Top Gainers